ScoreWhy is Guilin Sanjin Pharmaceutical Co., Ltd. ?
1
With ROE of 16.00%, it has a fair valuation with a 2.71 Price to Book Value
- Over the past year, while the stock has generated a return of -0.63%, its profits have risen by 47% ; the PEG ratio of the company is 0.4
- At the current price, the company has a high dividend yield of 4
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Guilin Sanjin Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Guilin Sanjin Pharmaceutical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Guilin Sanjin Pharmaceutical Co., Ltd.
-100.0%
0.29
25.78%
China Shanghai Composite
16.67%
1.14
14.96%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.31%
EBIT Growth (5y)
4.43%
EBIT to Interest (avg)
19.95
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.60
Tax Ratio
18.53%
Dividend Payout Ratio
67.60%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.16%
ROE (avg)
12.69%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
2.71
EV to EBIT
15.83
EV to EBITDA
12.53
EV to Capital Employed
3.56
EV to Sales
3.56
PEG Ratio
0.36
Dividend Yield
4.02%
ROCE (Latest)
22.52%
ROE (Latest)
16.00%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 717.58 MM
RAW MATERIAL COST(Y)
Fallen by -1.37% (YoY
-7What is not working for the Company
INTEREST(Q)
At CNY 3.09 MM has Grown at inf%
NET SALES(Q)
Lowest at CNY 464.04 MM
Here's what is working for Guilin Sanjin Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 717.58 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Raw Material Cost
Fallen by -1.37% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Guilin Sanjin Pharmaceutical Co., Ltd.
Net Sales
At CNY 464.04 MM has Fallen at -12.61%
over average net sales of the previous four periods of CNY 530.98 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Interest
At CNY 3.09 MM has Grown at inf%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
Lowest at CNY 464.04 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
